Medical Technology - Europe

Europe

The projected revenue in the Medical Technology market market in Europe is estimated to reach €152.90bn in 2024.
Among the markets, Medical Devices is expected to be the largest, with a projected market volume of €132.40bn in 2024.
The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 4.86%, resulting in a market volume of €193.80bn by 2029.
When compared globally, the United States is projected to generate the highest revenue, amounting to €195.70bn in 2024.
In Europe, Germany is leading the way in medical technology with its advanced research and development capabilities.

Key regions: United States, Germany, China, Japan, France

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Medical Technology market in Europe is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the positive trajectory of the industry. Customer preferences play a crucial role in shaping the Medical Technology market in Europe. Consumers are increasingly seeking advanced and innovative medical devices and technologies that can improve the quality of healthcare. They are also demanding personalized and patient-centric solutions that cater to their specific needs. This shift in customer preferences has led to the development and adoption of cutting-edge technologies such as telemedicine, wearable devices, and digital health solutions. Trends in the market further contribute to the growth of the Medical Technology industry in Europe. One prominent trend is the increasing focus on preventive healthcare and early disease detection. Governments and healthcare providers are investing in technologies that can help identify health risks at an early stage, leading to better treatment outcomes and reduced healthcare costs. Another trend is the rise of artificial intelligence and machine learning in medical devices, enabling more accurate diagnoses and personalized treatment plans. Local special circumstances also play a role in the development of the Medical Technology market in Europe. The region has a well-established healthcare infrastructure and a strong regulatory framework that ensures the safety and efficacy of medical devices. This attracts both domestic and international manufacturers to invest in the European market. Additionally, Europe has a large aging population, which drives the demand for medical devices and technologies that cater to the needs of elderly individuals. Underlying macroeconomic factors contribute to the growth of the Medical Technology market in Europe as well. The region has a stable and prosperous economy, which provides a favorable environment for investment and innovation. Government initiatives and policies that promote research and development in the healthcare sector further stimulate the growth of the industry. Additionally, Europe has a strong network of academic institutions and research centers that foster collaboration between industry and academia, leading to advancements in medical technology. In conclusion, the Medical Technology market in Europe is experiencing significant growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for advanced and innovative medical devices, the focus on preventive healthcare, the rise of artificial intelligence, the well-established healthcare infrastructure, the aging population, the stable economy, and the supportive government policies all contribute to the positive trajectory of the industry.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.